Assessment of Fibrinogen Level and Platelets Parameters among Vaccinated Healthy Individuals with COVID-19 Vaccine at Shendi Town
No Thumbnail Available
Date
2022-06-10
Journal Title
Journal ISSN
Volume Title
Publisher
جامعة الشيخ عبدالله البدري
Abstract
Abstract: Background: Covid-19 vaccine is an immunization method used to reduce coronavirus incidence but
lately caused life-threatening events such as thrombosis with thrombocytopenia syndrome. Methods: This is a case control study conducted at Shendi town to evaluate platelet parameters and fibrinogen levels in vaccinated healthy
individuals With Covid-19 vaccines between Augusts to November 2021. A total of (100) vaccinated healthy individual
With the Covid-19 vaccine was enrolled in the study as test groups, compared with (50) healthy volunteers as a control
group. Venous blood samples were transferred into Trisodium citrate and EDTA anticoagulant. Data was collected using
a questionnaire and the (SPSS) version (22) program was used for data analysis. Results: The study revealed that the
vaccinated healthy individuals were; (50%) male and (50%) female. The platelets parameter and fibrinogen indicated the
mean values of platelets count, mean platelets volume, platelets distribution width, platelet crit, and fibrinogen, in
Janssen vaccine groups, were (251.14 109\L), (8.39 fl), (15.6), (0.203%), and (158 mg\dl) respectively. The results study
revealed the mean of PLT, MPV, PDW, PCT, and Fibrinogen, in Astrazeneca vaccine groups, were (272.08 109\L),
(8.13fl), (15.56), (0.2211%), (159 mg/dl) respectively. Also explained the mean of PLT, MPV, PDW, PCT and
Fibrinogen, in Astrazeneca vaccine groups were (272.08 109\L), (8.13fl), (15.56), (0.2211%), (159 mg\dl) respectively
and in Janssen vaccine groups the mean values of PLT, MPV, PDW, PCT, Fibrinogen were ( 251.14 109\L), (8.39fl),
(15.63), (0.2034%), (158 mg\dl) respectively. Conclusions: Covid-19 vaccines are responsible for significant changes in
fibrinogen level in both AstraZeneca and Janssen vaccine groups.